Verve Therapeutics
Verve Therapeutics is a biotechnology company focused on developing gene-editing therapies to treat cardiovascular diseases. They leverage CRISPR-based technology to make precise edits to DNA, aiming to provide a one-time treatment for conditions such as high cholesterol. Founded in 2018, Verve has made significant strides, including partnerships with major pharmaceutical companies and securing substantial funding to advance their research. Their innovative approach aims to transform the treatment landscape for heart disease, offering potentially curative solutions rather than chronic management.Recent Posts by Verve Therapeutics
- Scientist, Next Generation Sequencing (NGS)EAST BOSTON, MAPosted 30+ days ago•Similar jobs
- Associate Director, Quality SystemsEAST BOSTON, MAPosted 30+ days ago•Similar jobs
- Associate Director, Analytical Development - CMCEAST BOSTON, MAPosted 30+ days ago•Similar jobs
- Senior Manager, Finance, Planning and Analysis (FP&A)EAST BOSTON, MAPosted 30+ days ago•Similar jobs
- Senior Research Associate, Preclinical PharmacologyEAST BOSTON, MAPosted 30+ days ago•Similar jobs
1-5 of 5